--- title: "'Big Short' Investor Michael Burry Makes $198 Healthcare Bet Ahead of Election Season — Here's Why" type: "News" locale: "en" url: "https://longbridge.com/en/news/295805136.md" description: "Michael Burry increased his stake in Molina Healthcare (MOH) to $198, viewing the post-earnings pullback as a buying opportunity. Despite beating Q2 revenue and EPS estimates, rising medical costs and weaker Marketplace enrollment caused stock dips. Burry cites Molina's long-term outlook and potential election-related policy catalysts for government-sponsored programs like Medicaid and Medicare as key reasons for his confidence." datetime: "2026-08-13T13:09:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295805136.md) - [en](https://longbridge.com/en/news/295805136.md) - [zh-HK](https://longbridge.com/zh-HK/news/295805136.md) generator: "portal-rs" --- # 'Big Short' Investor Michael Burry Makes $198 Healthcare Bet Ahead of Election Season — Here's Why The *Big Short* investor, Michael Burry, has added to his Molina Healthcare (MOH) position at $198. Burry said his Molina position had become smaller than his other large holdings after he moved money into other investments. He added to Molina to make it a full-sized position again. He also pointed to Molina's long-term outlook and the upcoming election season as reasons for his continued confidence. ### Claim 55% Off TipRanks - Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions - Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks For context, Molina Healthcare is a managed-care insurer focused on government-sponsored health programs, including Medicaid and Medicare. ## **Why Did Burry Add to Molina Healthcare?** Burry's purchase comes after Molina's second-quarter earnings triggered a pullback in the stock. The company reported $10.87 billion in revenue, beating the $10.83 billion consensus estimate. Adjusted EPS came in at $1.51, ahead of the $1.39 estimate. Molina also raised its full-year adjusted EPS guidance to at least $5.25. Despite the earnings beat and higher outlook, investors focused on rising medical costs. Molina's Medical Care Ratio rose to 92.2%, with its Marketplace MCR reaching 88.9% due to higher member acuity and risk adjustments. Jefferies analyst David Windley also flagged weaker-than-expected enrollment in the Marketplace business. He said the decline raised concerns about the segment's near-term performance. Still, Burry appears to view the post-earnings weakness as a buying opportunity. Molina stock remains up about 18% year to date, despite the recent pullback. ## **Burry Sees a Potential Election Catalyst** Burry also pointed to the upcoming election season as a potential catalyst for Molina. Molina runs much of its business through government-sponsored programs such as Medicaid and Medicare. That makes healthcare policy and election outcomes important for the insurer. Election cycles can bring changes to healthcare policy and government funding. They can also affect state contracts and the outlook for managed-care providers. Burry's comment suggests he sees the political backdrop as a potential boost for Molina. Still, the company will need to control medical costs and improve its Marketplace business. ## **Is MOH Stock Still a Buy Now?** On TipRanks, MOH has a Hold consensus rating based on three Buys, 11 Holds, and one Sell rating. The average Molina Healthcare price target of $215.23 implies 4.45% upside potential from current levels. ### Related Stocks - [MOH.US](https://longbridge.com/en/quote/MOH.US.md) - [JEF.US](https://longbridge.com/en/quote/JEF.US.md) ## Related News & Research - [MOH: H1 2026 saw record profit growth, robust cash flow, and major investments in green energy](https://longbridge.com/en/news/296931666.md) - [Molina Healthcare earnings beat estimates. The Medicaid insurer is confronting investor doubts.](https://longbridge.com/en/news/293530959.md) - [Parallax Volatility Advisers L.P. Purchases Shares of 1,623 Thermo Fisher Scientific Inc. $TMO](https://longbridge.com/en/news/297162592.md) - [Repligen CEO, CFO to join Wells Fargo Healthcare Conference analyst discussion](https://longbridge.com/en/news/297037160.md) - [Materialise Half-Year 2026 Report Highlights Portfolio Refocus and Growth in Medical, Software and Aerospace](https://longbridge.com/en/news/297181070.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**